Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05658159 · ClinicalTrials.gov registry record
Physiological and Dietary Characteristics of Boys and Girls High School Basketball Players
A clinical trial, sponsored by PepsiCo Global R&D.
- Completed
- Registry status
- 120
- Enrollment target
NCT05658159: Completed study, sponsored by PepsiCo Global R&D.
NCT05658159 is a clinical trial that has completed, run by PepsiCo Global R&D. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05658159 has completed, sponsored by PepsiCo Global R&D.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
In a population of boys and girls high school basketball players, the primary objectives are to assess 1) bone mineral density and vitamin D status, and 2) energy intake and dietary quality. The secondary objectives are to assess 1) nutrients related to bone health (calcium, magnesium, vitamin K, protein) and 2) protein intake over the day. Data collection takes place pre-, mid-, and post-season.
Primary Outcome
whole body
Interventions
- DIAGNOSTIC_TEST DXA scan
- DIAGNOSTIC_TEST Vitamin D
- OTHER Nutrition analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2023-04-27 |
What the finished NCT05658159 record still lists
NCT05658159 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which DXA scan is the first listed.
NCT05658159 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05658159 about?
NCT05658159 is a clinical study titled "Physiological and Dietary Characteristics of Boys and Girls High School Basketball Players". In a population of boys and girls high school basketball players, the primary objectives are to assess 1) bone mineral density and vitamin D status, and 2) energy intake and dietary quality. The secondary objectives are to assess 1) nutrients related to bone health (calcium, magnesium, vitamin K, p...
What is the current status of trial NCT05658159?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2022-11-01. Estimated completion is 2023-04-27.
What interventions are being tested in trial NCT05658159?
The interventions under investigation include: DXA scan (DIAGNOSTIC_TEST), Vitamin D (DIAGNOSTIC_TEST), Nutrition analysis (OTHER).
Who is sponsoring clinical trial NCT05658159?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI